STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,553,000 | -2.3% | 149,466 | +0.0% | 0.02% | 0.0% |
| Q4 2019 | $1,589,000 | +33.9% | 149,438 | +31.1% | 0.02% | +6.2% |
| Q3 2019 | $1,187,000 | -2.7% | 114,000 | +42.5% | 0.02% | +6.7% |
| Q2 2019 | $1,220,000 | -53.3% | 80,000 | -67.2% | 0.02% | -75.0% |
| Q4 2016 | $2,611,000 | -6.2% | 244,000 | -5.1% | 0.06% | -10.4% |
| Q3 2016 | $2,783,000 | – | 257,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |